Development of Human Anti-Influenza Monoclonal Antibodies for Treatment of Flu

Information

• Research Project
• 7946118

• ApplicationId

  7946118

• Core Project Number

  272200900014C-0-0-1

• Full Project Number

  272200900014C-0-0-1

• Serial Number

  0

• FOA Number

• Sub Project Id

• Project Start Date

  8/15/2009 - 15 years ago

• Project End Date

  8/14/2014 - 10 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2009

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• Crucell Holland B.V.

The overall objectives and scope of this contract is to advance the development of human monoclonal antibody (mAbs) products for treatment of Influenza A viral infections. The scope of work for this contract includes nonclinical, preclinical, and clinical development activities.

IC Name

• Activity

  N01

• Administering IC

  AI

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  13246602

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  855

• Ed Inst. Type

• Funding ICs

  NIAID:13246602\

• Funding Mechanism

  Contracts, Extramural

• Study Section

• Study Section Name

• Organization Name

  CRUCELL HOLLAND, BV

• Organization Department

• Organization DUNS

  415960780

• Organization City

  LEIDEN

• Organization State

• Organization Country

  NETHERLANDS

• Organization Zip Code

  2333 CN

• Organization District

  NETHERLANDS